Bioactive food components, inflammatory targets, and cancer prevention

Cancer Prevention Research

Volumn 2, Issue 3, 2009, Pages 200-208

  Kim, Young S ^a   Young, Matthew R ^b   Bobe, Gerd ^b   Colburn, Nancy H ^b   Milner, John A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID; CELL ADHESION MOLECULE; CHEMOKINE; CONJUGATED LINOLEIC ACID; CURCUMIN; CYCLOOXYGENASE 2; CYTOKINE; DIALLYL DISULFIDE; EPIGALLOCATECHIN GALLATE; FLAVONOID; GENISTEIN; GREEN TEA EXTRACT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LINOLEIC ACID; LUTEOLIN; MITOGEN ACTIVATED PROTEIN KINASE; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PROTEIN C JUN; QUERCETIN; RESVERATROL; RETINOL; SULFORAPHANE; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA; TRICHOSTATIN A; VITAMIN D; VORINOSTAT;

ANTIINFLAMMATORY ACTIVITY; CANCER GENETICS; CANCER GROWTH; CANCER PREVENTION; CANCER RISK; CARCINOGENESIS; CELL FUNCTION; CHRONIC INFLAMMATION; CYTOKINE PRODUCTION; DNA POLYMORPHISM; DRUG STRUCTURE; DRUG TARGETING; FEEDBACK SYSTEM; GENE EXPRESSION; GENE MUTATION; GENOTYPE; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

ANTI-INFLAMMATORY AGENTS; DIET; FOOD; HISTONE DEACETYLASES; HUMANS; HYDROXYPROSTAGLANDIN DEHYDROGENASES; INFLAMMATION; MODELS, BIOLOGICAL; NEOPLASMS; NF-KAPPA B; NUTRITIVE VALUE; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 68349100034     PISSN: 19406207     EISSN: None     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-08-0141     Document Type: Review

References (100)

1. Hudert CA, Weylandt KH, Lu Y, et al. Transgenic mice rich in endogenous ω-3 fatty acids are protected from colitis. Proc Natl Acad Sci U S A 2006;103:11276-11281 (Pubitemid 44156509)
2. Bachmeier BE, Mohrenz IV, Mirisola V, et al. Curcumin down-regulates the inflammatory cytokines CXCL1 and -2 in breast cancer cells via NFκB. Carcinogenesis 2008;29:779-789
3. Harper CE, Patel BB, Wang J, Eltoum IA, Lamartiniere CA. Epigallocatechin-3-gallate suppresses early stage, but not late stage prostate cancer in TRAMP mice: mechanisms of action. Prostate 2007;67:1576-1589 (Pubitemid 47536156)
4. Yang K, Popova NV, Yang WC, et al. Interaction of Muc2 and Apc on Wnt signaling and in intestinal tumorigenesis: potential role of chronic inflammation. Cancer Res 2008;68:7313-8225
5. Ell K, Xie B, Quon B, Quinn DI, Dwight-Johnson M, Lee PJ. Randomized controlled trial of collaborative care management of depression among low-income patients with cancer. J Clin Oncol 2008;26:4488-4496
6. Rose C, Stovall E, Ganz PA, Desch C, Hewitt M. Cancer quality alliance: blueprint for a better cancer care system. CA Cancer J Clin 2008;58:266-292
7. Available from: http://seer.cancer.gov/csr/1975-2003/sections.html
8. Cavaillon JM, Annane D. Compartmentalization of the inflammatory response in sepsis and SIRS. J Endotoxin Res 2006;12:151-170 (Pubitemid 47487521)
9. Kang NJ, Lee KW, Lee DE, et al. Cocoa procyanidins suppress transformation by inhibiting mitogen-activated protein kinase kinase. J Biol Chem 2008. [Epub ahead of print].
10. Barnes PJ, Karin M. Nuclear factor-κB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997;336:1066-1071 (Pubitemid 27163860)
11. Werner T, Haller D. Intestinal epithelial cell signalling and chronic inflammation: from the proteome to specific molecular mechanisms. Mutat Res 2007;622:42-57. (Pubitemid 47211180)
12. Karin M. NF-κB and cancer: mechanisms and targets. Mol Carcinog 2006;45:355-361
13. Chan SK, Griffith OL, Tai IT, Jones SJ. Meta-analysis of colorectal cancer gene expression profiling studies identifies consistently reported candidate biomarkers. Cancer Epidemiol Biomarkers Prev 2008;17:543-552
14. Karin M. The IκB kinase - a bridge between inflammation and cancer. Cell Res 2008;18:334-342
15. Inoue N, Nagao K, Wang YM, Noguchi H, Shirouchi B, Yanagita T. Dietary conjugated linoleic acid lowered tumor necrosis factor-α content and altered expression of genes related to lipid metabolism and insulin sensitivity in the skeletal muscle of Zucker rats. J Agric Food Chem 2006;54:7935-7939 (Pubitemid 44645821)
16. Cao H, Kelly MA, Kari F, et al. Green tea increases anti-inflammatory tristetraprolin and decreases pro-inflammatory tumor necrosis factor mRNA levels in rats. J Inflamm 2007;4:1-12. (Pubitemid 46197003)
17. Manach C, Morand C, Texier O, et al. Quercetin metabolites in plasma of rats fed diets containing rutin or quercetin. J Nutr 1995;125:1911-1922
18. Shimoi K, Saka N, Nozawa R, et al. Deglucuronidation of a flavonoid, luteolin monoglucuronide, during inflammation. Drug Metab Dispos 2001;29:1521-1524 (Pubitemid 33111582)
19. Comalada M, Ballester I, Bailon E, et al. Inhibition of pro-inflammatory markers in primary bone marrow-derived mouse macrophages by naturally occurring flavonoids: analysis of the structure-activity relationship. Biochem Pharmacol 2006;72:1010-1021 (Pubitemid 44374465)
20. Xagorari A, Papapetropoulos A, Mauromatis A, Economou M, Fotsis T, Roussos C. Luteolin inhibits an endotoxin-stimulated phosphorylation cascade and proinflammatory cytokine production in macrophages. J Pharmacol Exp Ther 2001;296:181-187 (Pubitemid 32015077)
21. Manach C, Scalbert A, Morand C, Rémésy C, Jiménez L. Polyphenols: food sources and bioavailability. Am J Clin Nutr 2004;79:727-747
22. Adachi M, Kurotani R, Morimura K, et al. Peroxisome proliferator activated receptor γ in colonic epithelial cells protects against experimental inflammatory bowel disease. Gut 2006;55:1104-1113 (Pubitemid 44085676)
23. 2 via the PI3 kinase and AKT pathway. J Biol Chem 2007;282:5356-5366 (Pubitemid 47093760)
24. Crosby MB, Svenson J, Gilkeson GS, Nowling TK. A novel PPAR response element in the murine iNOS promoter. Mol Immunol 2005;42:1303-1310 (Pubitemid 40798946)
25. Dubuquoy L, Jansson EE, Deeb S, et al. Impaired expression of peroxisome proliferator-activated receptor γ in ulcerative colitis. Gastroenterology 2003;124:1265-1276 (Pubitemid 36531802)
26. Ewaschuk JB, Walker JW, Diaz H, Madsen KL. Bioproduction of conjugated linoleic acid by probiotic bacteria occurs in vitro and in vivo in mice. J Nutr 2006;136:1483-1487 (Pubitemid 43765349)
27. Pascual G, Fong AL, Ogawa S, et al. A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-γ. Nature 2005;437:759-763 (Pubitemid 41486547)
28. Kelly D, Campbell JI, King TP, et al. Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-γ and RelA. Nat Immunol 2004;5:104-112 (Pubitemid 38081475)
29. Cornelis MC, El-Sohemy A, Campos H. Genetic polymorphism of the adenosine A2A receptor is associated with habitual caffeine consumption. Am J Clin Nutr 2007;86:240-244 (Pubitemid 47041616)
30. Chan SK, Griffith OL, Tai IT, Jones SJM. Meta-analysis of colorectal cancer gene expression profiling studies identifies consistently reported candidate biomarkers. Cancer Epidemiol Biomarkers Prev 2008;17:543-552
31. Bitzer M, von Gersdorff G, Liang D, et al. A mechanism of suppression of TGF-β/SMAD signaling by NF-κB/RelA. Genes Dev 2000;14:187-197 (Pubitemid 30070984)
32. Nguyen KA, Cao Y, Chen JR, Townsend CM, Jr., Ko TC. Dietary fiber enhances a tumor suppressor signaling pathway in the gut. Ann Surg 2006;243:619-625 (Pubitemid 44305573)
33. 3. Am J Physiol Gastrointest Liver Physiol 2002;283:G864-74.
34. Yu Z, Tang Y, Hu D, Li J. Inhibitory effect of genistein on mouse colon cancer MC-26 cells involved TGF-β1/Smad pathway. Biochem Biophys Res Commun 2005;333:827-832 (Pubitemid 40854233)
35. Schmierer B, Tournier AL, Bates PA, Hill CS. Mathematical modeling identifies Smad nucleocytoplasmic shuttling as a dynamic signal-interpreting system. Proc Natl Acad Sci U S A 2008;105:6608-6613 (Pubitemid 351754554)
36. Ammanamanchi S, Brattain MG. Restoration of transforming growth factor-β signaling through receptor RI induction by histone deacetylase activity inhibition in breast cancer cells. J Biol Chem 2004;279:32620-32625 (Pubitemid 39014719)
37. Yan M, Rerko RM, Platzer P, et al. 15-Hydroxyprostaglandin dehydrogenase, a COX-2 oncogene antagonist, is a TGF-β-induced suppressor of human gastrointestinal cancers. Proc Natl Acad Sci U S A 2004;101:17468-17473 (Pubitemid 39657428)
38. Monteleone G, Mann J, Monteleone I, et al. A failure of transforming growth factor-β1 negative regulation maintains sustained NF-κB activation in gut inflammation. J Biol Chem 2004;279:3925-3932 (Pubitemid 38198975)
39. Puskás LG, Nagy ZB, Giricz Z, et al. Cholesterol diet-induced hyperlipidemia influences gene expression pattern of rat hearts: a DNA microarray study. FEBS Lett 2004;562:99-104. (Pubitemid 38388454)
40. Kang JS, Saunier EF, Akhurst RJ, Derynck R. The type I TGF-β receptor is covalently modified and regulated by sumoylation. Nat Cell Biol 2008;10:654-664 (Pubitemid 351772931)
41. Kuhn DJ, Burns AC, Kazi A, Dou QP. Direct inhibition of the ubiquitin-proteasome pathway by ester bond-containing green tea polyphenols is associated with increased expression of sterol regulatory element-binding protein 2 and LDL receptor. Biochim Biophys Acta 2004;1682:1-10. (Pubitemid 38670529)
42. Ammanamanchi S, Brattain MG. Restoration of transforming growth factor-β signaling through receptor RI induction by histone deacetylase activity inhibition in breast cancer cells. J Biol Chem 2004;279:32620-32625 (Pubitemid 39014719)
43. Periyasamy S, Ammanamanchi S, Tillekeratne MP, Brattain MG. Repression of transforming growth factor-β receptor type I promoter expression by Sp1 deficiency. Oncogene 2000;19:4660-4667 (Pubitemid 30777634)
44. Hinshelwood RA, Huschtscha LI, Melki J, et al. Concordant epigenetic silencing of transforming growth factor-β signaling pathway genes occurs early in breast carcinogenesis. Cancer Res 2007;67:11517-11527
45. Akhurst RJ, Derynck R. TGF-β signaling in cancer - a double-edged sword. Trends Cell Biol 2001;11:S44-51. (Pubitemid 32952643)
46. Yoshikawa M, Hishikawa K, Marumo T, Fujita T. Inhibition of histone deacetylase activity suppresses epithelial-to-mesenchymal transition induced by TGF-β1 in human renal epithelial cells. J Am Soc Nephrol 2007;18:58-65. (Pubitemid 46053422)
47. Dashwood RH, Ho E. Dietary histone deacetylase inhibitors: from cells to mice to man. Semin Cancer Biol 2007;17:363-369 (Pubitemid 47369168)
48. Myzak MC, Tong P, Dashwood WM, Dashwood RH, Ho E. Sulforaphane retards the growth of human PC-3 xenografts and inhibits HDAC activity in human subjects. Exp Biol Med (Maywood) 2007;232:227-234 (Pubitemid 46203291)
49. Druesne N, Pagniez A, Mayeur C, et al. Diallyl disulfide (DADS) increases histone acetylation and p21(waf1/cip1) expression in human colon tumor cell lines. Carcinogenesis 2004;25:1227-1236 (Pubitemid 38968051)
50. Tong M, Ding Y, Tai HH. Histone deacetylase inhibitors and transforming growth factor-β induce 15-hydroxyprostaglandin dehydrogenase expression in human lung adenocarcinoma cells. Biochem Pharmacol 2006;72:701-709 (Pubitemid 44233546)
51. Backlund MG, Mann JR, Holla VR, et al. 15-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancer. J Biol Chem 2005;280:3217-3223
52. Myung SJ, Rerko RM, Yan M, et al. 15-Hydroxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumorigenesis. Proc Natl Acad Sci U S A 2006;103:12098-12102 (Pubitemid 44215817)
53. Moreno J, Krishnan AV, Swami S, Nonn L, Peehl DM, Feldman D. Regulation of prostaglandin metabolism by calcitriol attenuates growth stimulation in prostate cancer cells. Cancer Res 2005;65:7917-7925 (Pubitemid 41297270)
54. Anand P, Sundaram C, Jhurani S, Kunnumakkara AB, Aggarwal BB. Curcumin and cancer: an "old-age" disease with an "age-old" solution. Cancer Lett 2008;267:133-164
55. Lechner D, Bajna E, Adlercreutz H, Cross HS. Genistein and 17β-estradiol, but not equol, regulate vitamin D synthesis in human colon and breast cancer cells. Anticancer Res 2006;26:2597-2603 (Pubitemid 44155540)
56. Kállay E, Adlercreutz H, Farhan H, et al. Phytoestrogens regulate vitamin D metabolism in the mouse colon: relevance for colon tumor prevention and therapy. J Nutr 2002;132:3490S-3S. (Pubitemid 35315825)
57. Gilad LA, Tirosh O, Schwartz B. Phytoestrogens regulate transcription and translation of vitamin D receptor in colon cancer cells. J Endocrinol 2006;191:387-398 (Pubitemid 44830614)
58. Rao CV, Wang CX, Simi B, et al. Enhancement of experimental colon cancer by genistein. Cancer Res 1997;57:3717-3722 (Pubitemid 27381214)
59. Lee SK, Zhang W, Sanderson BJ. Selective growth inhibition of human leukemia and human lymphoblastoid cells by resveratrol via cell cycle arrest and apoptosis induction. J Agric Food Chem 2008;56:7572-7577
60. Rocha-Lima CM, Soares HP, Raez LE, Singal R. EGFR targeting of solid tumors. Cancer Control 2007;14:295-304.
61. 2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy. Nat Med 2002;8:289-293 (Pubitemid 34250108)
62. Coffey RJ, Hawkey CJ, Damstrup L, et al. Epidermal growth factor receptor activation induces nuclear targeting of cyclooxygenase-2, basolateral release of prostaglandins, and mitogenesis in polarizing colon cancer cells. Proc Nati Acad Sci U S A 1997;94:657-662 (Pubitemid 27053689)
63. Oshima M, Dinchuk JE, Kargman SL, et al. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 1996;87:803-809 (Pubitemid 26404280)
64. Kunnumakkara AB, Anand P, Aggarwal BR. Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Left 2008. [Epub ahead of print].
65. Peng G, Dixon DA, Muga SJ, Smith TJ, Wargovich MJ. Green tea polyphenol (-)-epigallocatechin-3-gallate inhibits cyclooxygenase-2 expression in colon carcinogenesis. Mol Carcinog 2006;45:309-319 (Pubitemid 43749198)
66. Krishnan AV, Moreno J, Nonn L, Swami S, Peehl DM, Feldman D. Calcitriol as a chemopreventive and therapeutic agent in prostate cancer: role of anti-inflammatory activity. J Bone Miner Res 2007;22 Suppl 2:V74-80. (Pubitemid 351304654)
67. Hooshmand S, Soung do Y, Lucas EA, Madihally SV, Levenson CW, Arjmandi BH. Genistein reduces the production of proinflammatory molecules in human chondrocytes. J Nutr Biochem 2007;18:609-614
68. Zykova TA, Zhu F, Zhai X, et al. Resveratrol directly targets COX-2 to inhibit carcinogenesis. Mol Carcinog 2008. [Epub ahead of print].
69. Stachowska F, Baœkiewicz-Masiuk M, Dziedziejko V, et al. Conjugated linoleic acids can change phagocytosis of human monocytes/macrophages by reduction in Cox-2 expression. Lipids 2007;42:707-716 (Pubitemid 47328755)
70. Sauer J, Richter KK, Pool-Zobel BL. Physiological concentrations of butyrate favorably modulate genes of oxidative and metabolic stress in primary human colon cells. J Nutr Biochem 2007;18:736-745 (Pubitemid 47600651)
71. Grimble RF, Howell WM, O'Reilly G, et al. The ability of fish oil to suppress tumor necrosis factor a production by peripheral blood mononuclear cells in healthy men is associated with polymorphisms in genes that influence tumor necrosis factor α production. Am J Clin Nutr 2002;76:454-459 (Pubitemid 34804072)
72. Fernandez-Real JM, Broch M, Vendrell J, Richart C, Ricart W. Interleukin-6 gene polymorphism and lipid abnormalities in healthy subjects. J Clin Endocrinol Metab 2000;85:1 334-339 (Pubitemid 32269397)
73. Ulrich CM, Whitton J, Yu JH, et al. PTGS2 (COX-2) -765G > C promoter variant reduces risk of colorectal adenoma among nonusers of nonsteroidal anti-inflammatory drugs. Cancer Epidemiol Biomarkers Prev 2005;14:616-619
74. Shu XO, Gao YT, Cai Q, et al. Genetic polymorphisms in the TGF-β1 gene and breast cancer survival: a report from the Shanghai Breast Cancer Study. Cancer Res 2004;64:836-839 (Pubitemid 38176881)
75. Rosmond R, Chagnon M, Bouchard C, Bjorntorp P. Increased abdominal obesity, insulin and glucose levels in nondiabetic subjects with a T29C polymorphism of the transforming growth factor-β1 gene. Horm Res 2003;59:191-194 (Pubitemid 36356913)
76. Chan MM. Inhibition of tumor necrosis factor by curcumin, a phytochemical. Biochem Pharmacol 1995;49:1551-1556
77. Jiang H, Deng CS, Zhang M, Xia J. Curcumin-attenuated trinitrobenzene sulphonic acid induces chronic colitis by inhibiting expression of cyclooxygenase-2. World J Gastroenterol 2006;12:3848-3853 (Pubitemid 44028396)
78. Kumazawa Y, Kawaguchi K, Takimoto H. Immunomodulating effects of flavonoicls on acute and chronic inflammatory responses caused by tumor necrosis factor α. Curr Pharm Des 2006;12:4271-4279 (Pubitemid 44669755)
79. Davis JN, Kucuk O, Djuric Z, Sarkar FH. Soy isoflavone supplementation in healthy men prevents NF-κB activation by TNF-α in blood lymphocytes. Free Radic Biol Med 2001;30:1293-1302 (Pubitemid 32463940)
80. Xagorari A, Roussos C, Papapetropoulos A. Inhibition of LPS-stimulated pathways in macrophages by the flavonoid luteolin. Br J Pharmacol 2002;136:1058-1064 (Pubitemid 34888383)
81. Kotanidou A, Xagorari A, Bagli E, et al. Luteolin reduces lipopolysaccharide-induced lethal toxicity and expression of proinflammatory molecules in mice. Am J Respir Crit Care Med 2002;165:818-823 (Pubitemid 34229653)
82. Caughey GE, Mantzioris E, Gibson RA, Cleland LG, James MJ. The effect on human tumor necrosis factor α and interleukin 1β production of diets enriched in n-3 fatty acids from vegetable oil or fish oil. Am J Clin Nutr 1996;63:116-122 (Pubitemid 26005735)
83. 2 analog on cancer cell proliferation and cytokine expression. Steroids 2001;66:319-325 (Pubitemid 32140910)
84. Vanden Berghe W, Dijsselbloem N, Vermeulen L, Ndlovu N, Boone E, Haegeman G. Attenuation of mitogen- and stress-activated protein kinase-1-driven nuclear factor-κB gene expression by soy isoflavones does not require estrogenic activity. Cancer Res 2006;66:4852-4862
85. Choi EM. Modulatory effects of luteolin on osteoblastic function and inflammatory mediators in osteoblastic MC3T3-E1 cells. Cell Biol Int 2007;31:870-877
86. Kandere-Grzybowska K, Kempuraj D, Cao J, Cetrulo CL, Theoharides TC. Regulation of IL-1-induced selective IL-6 release from human mast cells and inhibition by quercetin. Br J Pharmacol 2006;148:208-215 (Pubitemid 43873039)
87. Lührs H, Gerke T, Müller JG, et al. Butyrate inhibits NF-κB activation in lamina propria macrophages of patients with ulcerative colitis. Scand J Gastroenterol 2002;37:458-466
88. Manna SK, Mukhopadhyay A, Aggarwal BB. Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-κB, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation. J Immunol 2000;164:6509-6519 (Pubitemid 30408836)
89. Tong X, Yin L, Joshi S, Rosenberg DW, Giardina C. Cyclooxygenase-2 regulation in colon cancer cells: modulation of RNA polymerase II elongation by histone deacetylase inhibitors. J Biol Chem 2005;280:15503-15509 (Pubitemid 40616665)
90. Degner SC, Kemp MQ, Bowden GT, Romagnolo DF. Conjugated linoleic acid attenuates cyclooxygenase-2 transcriptional activity via an anti-AP-1 mechanism in MCF-7 breast cancer cells. J Nutr 2006;136:421-427
91. Hooshmand S, Soung do Y, Lucas EA, Madihally SV, Levenson CW, Arjmandi BH. Genistein reduces the production of proinflammatory molecules in human chondrocytes. J Nutr Biochem 2007;18:609-614
92. Stempelj M, Kedinger M, Augenlicht L, Klampfer L. Essential role of the JAK/STAT1 signaling pathway in the expression of inducible nitric-oxide synthase in intestinal epithelial cells and its regulation by butyrate. J Biol Chem 2007;282:9797-9804
93. Schwab M, Reynders V, Shastri Y, Loitsch S, Stein J, Schröder O. Role of nuclear hormone receptors in butyrate-mediated up-regulation of the antimicrobial peptide cathelicidin in epithelial colorectal cells. Mol Immunol 2007;44:2107-2114 (Pubitemid 44827236)
94. Yu Y, Correll PH, Vanden Heuvel JP. Conjugated linoleic acid decreases production of pro-inflammatory products in macrophages: evidence for PPAR γ-dependent mechanism. Biochim Biophys Acta 2002;1581:89-99. (Pubitemid 34521887)
95. Grimble RF. The effects of sulfur amino acid intake on immune function in humans. J Nutr 2006;136:1660S-5S.
96. Vetrano AM, Heck DE, Mariano TM, Mishin V, Laskin DL, Laskin JD. Characterization of the oxidase activity in mammalian catalase. J Biol Chem 2005;280:35372-35381 (Pubitemid 41532726)
97. Kristiansen OP, Mandrup-Poulsen T. Interleukin-6 and diabetes: the good, the bad, or the indifferent? Diabetes 2005;54 Suppl 2:S114-24.
98. Testa R, Olivieri F, Bonfigli AR, et al. Interleukin-6-174 G > C polymorphism affects the association between IL-6 plasma levels and insulin resistance in type 2 diabetic patients. Diabetes Res Clin Pract 2006;71:299-305.
99. Koh WP, Yuan JM, van den Berg D, Lee HP, Yu MC. Interaction between cyclooxygenase-2 gene polymorphism and dietary n-6 polyunsaturated fatty acids on colon cancer risk: the Singapore Chinese Health Study. Br J Cancer 2004;90:1760-1764
100. Murtaugh MA, Ma KN, Caan BJ, et al. Interactions of peroxisome proliferator-activated receptor γ and diet in etiology of colorectal cancer. Cancer Epidemiol Biomarkers Prev 2005;14:1224-1229 (Pubitemid 40656471)